Pages that link to "Q43809241"
Jump to navigation
Jump to search
The following pages link to Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women (Q43809241):
Displaying 23 items.
- Timing and duration of menopausal hormone treatment may affect cardiovascular outcomes (Q24626206) (← links)
- Equine estrogens differentially inhibit DNA fragmentation induced by glutamate in neuronal cells by modulation of regulatory proteins involved in programmed cell death (Q24795759) (← links)
- Potential role of the interaction between equine estrogens, low-density lipoprotein (LDL) and high-density lipoprotein (HDL) in the prevention of coronary heart and neurodegenerative diseases in postmenopausal women (Q24800416) (← links)
- Glutamate-induced apoptosis in primary cortical neurons is inhibited by equine estrogens via down-regulation of caspase-3 and prevention of mitochondrial cytochrome c release (Q24806246) (← links)
- Protection of cortical cells by equine estrogens against glutamate-induced excitotoxicity is mediated through a calcium independent mechanism (Q24810197) (← links)
- The Effect of Menopausal Hormone Therapies on Breast Cancer: Avoiding the Risk (Q26821782) (← links)
- Molecular characterization of a B-ring unsaturated estrogen: Implications for conjugated equine estrogen components of Premarin (Q27648855) (← links)
- Cellular and molecular effects of resveratrol in health and disease (Q28252560) (← links)
- The potential for estrogens in preventing Alzheimer's disease and vascular dementia (Q28263673) (← links)
- Glutamate-induced apoptosis in neuronal cells is mediated via caspase-dependent and independent mechanisms involving calpain and caspase-3 proteases as well as apoptosis inducing factor (AIF) and this process is inhibited by equine estrogens (Q28575769) (← links)
- Mitochondrial mechanisms of estrogen neuroprotection (Q33927797) (← links)
- Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds (Q34658945) (← links)
- Antioxidants as treatment for neurodegenerative disorders (Q34974866) (← links)
- Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's (Q35207804) (← links)
- Risk factors for hot flashes among women undergoing the menopausal transition: baseline results from the Midlife Women's Health Study (Q36069122) (← links)
- Menopausal hormone therapy (Q36152764) (← links)
- A new approach to menopausal therapy: the tissue selective estrogen complex (Q37352516) (← links)
- Anti-atherogenic effects of resveratrol (Q37756520) (← links)
- Effect of oestrone on membrane fluidity of erythrocytes is mediated by a nitric oxide-dependent pathway: An electron paramagnetic resonance study (Q44169295) (← links)
- Resveratrol: from diet to topical usage. (Q50072963) (← links)
- Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. (Q54606528) (← links)
- Alzheimer's disease, estrogens, and clinical trials: a case study in drug development for complex disorders (Q57074482) (← links)
- Is the WHI relevant to HRT started in the perimenopause? (Q81002469) (← links)